214 related articles for article (PubMed ID: 25307865)
21. Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines.
Tischkowitz M; Huang S; Banerjee S; Hague J; Hendricks WPD; Huntsman DG; Lang JD; Orlando KA; Oza AM; Pautier P; Ray-Coquard I; Trent JM; Witcher M; Witkowski L; McCluggage WG; Levine DA; Foulkes WD; Weissman BE
Clin Cancer Res; 2020 Aug; 26(15):3908-3917. PubMed ID: 32156746
[TBL] [Abstract][Full Text] [Related]
22. Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.
Jelinic P; Mueller JJ; Olvera N; Dao F; Scott SN; Shah R; Gao J; Schultz N; Gonen M; Soslow RA; Berger MF; Levine DA
Nat Genet; 2014 May; 46(5):424-6. PubMed ID: 24658004
[TBL] [Abstract][Full Text] [Related]
23. SMARCA4-deficient undifferentiated carcinoma of the ovary (small cell carcinoma, hypercalcemic type): clinicopathologic and immunohistochemical study of 3 cases.
Agaimy A; Thiel F; Hartmann A; Fukunaga M
Ann Diagn Pathol; 2015 Oct; 19(5):283-7. PubMed ID: 26123103
[TBL] [Abstract][Full Text] [Related]
24. Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type.
Jelinic P; Schlappe BA; Conlon N; Tseng J; Olvera N; Dao F; Mueller JJ; Hussein Y; Soslow RA; Levine DA
Mod Pathol; 2016 Jan; 29(1):60-6. PubMed ID: 26564006
[TBL] [Abstract][Full Text] [Related]
25. Loss of SMARCA4 Expression Is Both Sensitive and Specific for the Diagnosis of Small Cell Carcinoma of Ovary, Hypercalcemic Type.
Conlon N; Silva A; Guerra E; Jelinic P; Schlappe BA; Olvera N; Mueller JJ; Tornos C; Jungbluth AA; Young RH; Oliva E; Levine D; Soslow RA
Am J Surg Pathol; 2016 Mar; 40(3):395-403. PubMed ID: 26645725
[TBL] [Abstract][Full Text] [Related]
26. Loss of SMARCA4 (BRG1) protein expression as determined by immunohistochemistry in small-cell carcinoma of the ovary, hypercalcaemic type distinguishes these tumours from their mimics.
Clarke BA; Witkowski L; Ton Nu TN; Shaw PA; Gilks CB; Huntsman D; Karnezis AN; Sebire N; Lamovec J; Roth LM; Stewart CJ; Hasselblatt M; Foulkes WD; McCluggage WG
Histopathology; 2016 Nov; 69(5):727-738. PubMed ID: 27100627
[TBL] [Abstract][Full Text] [Related]
27. Multimodal molecular analysis of an atypical small cell carcinoma of the ovary, hypercalcemic type.
David MP; Venkatramani R; Lopez-Terrada DH; Roy A; Patil N; Fisher KE
Cold Spring Harb Mol Case Stud; 2018 Oct; 4(5):. PubMed ID: 30275002
[TBL] [Abstract][Full Text] [Related]
28. Ovarian carcinoma in children with constitutional mutation of SMARCA4: single-family report and literature review.
Pastorczak A; Krajewska K; Urbanska Z; Szmyd B; Salacinska-Los E; Kobos J; Mlynarski W; Trelinska J
Fam Cancer; 2021 Oct; 20(4):355-362. PubMed ID: 33907931
[TBL] [Abstract][Full Text] [Related]
29. Ovarian small cell carcinoma in one of a pair of monozygous twins.
Fahiminiya S; Sabbaghian N; Albrecht S; Nadaf J; Callegaro-Filho D; Foulkes WD
Fam Cancer; 2019 Apr; 18(2):161-163. PubMed ID: 30284660
[TBL] [Abstract][Full Text] [Related]
30. Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): Comprehensive management of a newly diagnosed young adult.
Pressey JG; Dandoy CE; Pater LE; Sroga Rios J; Sisson R; Dasgupta R; Szabo S
Gynecol Oncol; 2020 Sep; 158(3):538-546. PubMed ID: 32654763
[TBL] [Abstract][Full Text] [Related]
31. SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type.
Andrianteranagna M; Cyrta J; Masliah-Planchon J; Nemes K; Corsia A; Leruste A; Holdhof D; Kordes U; Orbach D; Corradini N; Entz-Werle N; Pierron G; Castex MP; Brouchet A; Weingertner N; Ranchère D; Fréneaux P; Delattre O; Bush J; Leary A; Frühwald MC; Schüller U; Servant N; Bourdeaut F
J Pathol; 2021 Sep; 255(1):1-15. PubMed ID: 33999421
[TBL] [Abstract][Full Text] [Related]
32. Identification of Driver Mutations in Rare Cancers: The Role of SMARCA4 in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT).
Lang JD; Hendricks WPD
Methods Mol Biol; 2018; 1706():367-379. PubMed ID: 29423809
[TBL] [Abstract][Full Text] [Related]
33. Case Report of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (Ovarian Rhabdoid Tumor) with
Simões MFE; da Costa AABA; Silva TN; Fernandes L; Bovolim G; Torrezan GT; Carraro DM; Baiocchi G; Menezes ANO; Santana Dos Santos E; De Brot L
Curr Oncol; 2022 Jan; 29(2):411-422. PubMed ID: 35200537
[TBL] [Abstract][Full Text] [Related]
34. Small Cell Carcinoma of Ovary, Hypercalcemic Type (Malignant Rhabdoid Tumor of Ovary) with Loss of SMARCA4 (BRG1) Expression: Report of Two Cases.
Sahay A; Kante K; Menon S; Ghosh J; Kerkar RA; Deodhar KK
Turk Patoloji Derg; 2020; 1(1):261-267. PubMed ID: 32149361
[TBL] [Abstract][Full Text] [Related]
35. Association of Li-Fraumeni Syndrome With Small Cell Carcinoma of the Ovary, Hypercalcemic Type and Concurrent Pleomorphic Liposarcoma of the Cervix.
Tandon B; Hagemann IS; Maluf HM; Pfeifer JD; Al-Kateb H
Int J Gynecol Pathol; 2017 Nov; 36(6):593-599. PubMed ID: 28177947
[TBL] [Abstract][Full Text] [Related]
36. Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade.
Jelinic P; Ricca J; Van Oudenhove E; Olvera N; Merghoub T; Levine DA; Zamarin D
J Natl Cancer Inst; 2018 Jul; 110(7):787-790. PubMed ID: 29365144
[TBL] [Abstract][Full Text] [Related]
37. Small Cell Carcinoma of Ovary, Hypercalcemic Type: Cytologic, Histopathologic, and Immunohistochemical Landscapes of a Rare Case.
Aggarwal D; Gupta P; Chhabra P; Peters NJ; Bansal D; Srinivasan R; Kakkar N
J Pediatr Adolesc Gynecol; 2021 Feb; 34(1):98-102. PubMed ID: 32750414
[TBL] [Abstract][Full Text] [Related]
38. Small Cell Carcinoma of the Ovary, Hypercalcemic Type, in a 12-Month-Old Girl.
Atwi D; Quinton MR; Kiser RM; Pokala HR; Rooms LM; Yu Z
Pediatr Dev Pathol; 2021; 24(5):493-497. PubMed ID: 34047234
[TBL] [Abstract][Full Text] [Related]
39. [SCCOHT/ovarian rhabdoid tumor: A case report].
Bourgoin R; Cornelis F; Masliah-Planchon J; Genestie C; Laé M
Ann Pathol; 2019 Sep; 39(5):357-363. PubMed ID: 30928254
[TBL] [Abstract][Full Text] [Related]
40. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
